GIACOMELLI, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 12.408
NA - Nord America 3.461
EU - Europa 1.697
SA - Sud America 1.496
AF - Africa 137
OC - Oceania 46
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.247
Nazione #
SG - Singapore 6.982
US - Stati Uniti d'America 3.266
CN - Cina 2.114
HK - Hong Kong 2.071
BR - Brasile 1.165
VN - Vietnam 697
GB - Regno Unito 609
IT - Italia 298
DE - Germania 218
AR - Argentina 142
IN - India 138
CA - Canada 116
NL - Olanda 102
ID - Indonesia 97
EC - Ecuador 67
JP - Giappone 62
UA - Ucraina 62
ZA - Sudafrica 61
MX - Messico 58
BD - Bangladesh 55
TR - Turchia 52
FR - Francia 47
PL - Polonia 42
AU - Australia 41
ES - Italia 40
RU - Federazione Russa 39
CO - Colombia 36
FI - Finlandia 36
PY - Paraguay 30
AT - Austria 27
SE - Svezia 26
CZ - Repubblica Ceca 25
CL - Cile 21
PE - Perù 21
PT - Portogallo 18
EG - Egitto 16
MA - Marocco 16
PK - Pakistan 14
IQ - Iraq 13
IL - Israele 12
KZ - Kazakistan 12
IR - Iran 11
BG - Bulgaria 9
DK - Danimarca 9
LT - Lituania 9
RO - Romania 9
TN - Tunisia 9
SA - Arabia Saudita 8
CH - Svizzera 7
GR - Grecia 7
UZ - Uzbekistan 7
AL - Albania 6
IE - Irlanda 6
KE - Kenya 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
EE - Estonia 5
JO - Giordania 5
LB - Libano 5
LU - Lussemburgo 5
LV - Lettonia 5
OM - Oman 5
BE - Belgio 4
GH - Ghana 4
GT - Guatemala 4
HN - Honduras 4
KW - Kuwait 4
RS - Serbia 4
SI - Slovenia 4
SN - Senegal 4
VE - Venezuela 4
AF - Afghanistan, Repubblica islamica di 3
AZ - Azerbaigian 3
BO - Bolivia 3
IS - Islanda 3
KR - Corea 3
PH - Filippine 3
QA - Qatar 3
YT - Mayotte 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MY - Malesia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TL - Timor Orientale 2
TW - Taiwan 2
ZM - Zambia 2
AD - Andorra 1
Totale 19.220
Città #
Hong Kong 2.048
Singapore 1.365
Hefei 1.101
Ashburn 944
Boardman 616
London 526
Shanghai 350
Dallas 331
Beijing 292
Ho Chi Minh City 264
Council Bluffs 189
Hanoi 139
Los Angeles 119
São Paulo 98
Pune 94
San Francisco 92
Amsterdam 75
Munich 61
Toronto 61
Rome 59
Washington 51
Seattle 48
Santa Clara 47
Tokyo 45
New York 43
Haiphong 35
Warsaw 35
Brooklyn 30
Brasília 27
Rio de Janeiro 26
Ankara 25
Da Nang 25
Montreal 24
Johannesburg 23
Turku 23
Biên Hòa 22
Chicago 22
Guayaquil 21
Stockholm 21
Curitiba 20
Quito 20
Thái Bình 20
West Jordan 20
Brno 19
Boston 18
Guangzhou 18
Mexico City 18
Porto Alegre 18
Bari 17
Buenos Aires 17
Hải Dương 17
Jinan 17
Belo Horizonte 15
Campinas 15
Chennai 15
Manchester 15
Frankfurt am Main 14
Guarulhos 14
Lima 14
Phoenix 14
Atlanta 13
Can Tho 13
Manaus 13
Melbourne 13
Sydney 13
Vienna 13
Helsinki 12
Lấp Vò 12
Charlotte 11
Hortolândia 11
Naples 11
Paris 11
Qingdao 11
Barcelos 10
Cape Town 10
Jakarta 10
Milan 10
Ninh Bình 10
Salvador 10
Secaucus 10
Asunción 9
Cairo 9
Hanover 9
Nuremberg 9
Ribeirão Preto 9
Santo André 9
The Dalles 9
Bogotá 8
Canberra 8
Changsha 8
Fortaleza 8
Goiânia 8
Hangzhou 8
Jaguariúna 8
Joinville 8
Maceió 8
Osasco 8
Bắc Giang 7
Carapicuíba 7
Cotia 7
Totale 10.163
Nome #
------- 215
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 209
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 209
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 204
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 199
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 192
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 185
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 184
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 182
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 175
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 169
A comprehensive review on adult onset Still's disease 167
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 167
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 167
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 163
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 160
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 159
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 153
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 152
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 152
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 151
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 129
Adult-onset Still's disease with elderly onset: results from a multicentre study 126
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 123
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 122
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 101
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 98
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 98
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 96
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 95
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 91
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 90
Cytokine storm syndrome in severe COVID-19 90
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 89
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 87
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 86
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 84
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 84
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 83
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 80
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 80
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 78
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 78
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 77
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 75
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 74
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 73
Cardiovascular disease in primary sjögren’s syndrome 69
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 69
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 65
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 65
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 60
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 57
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 56
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 55
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 54
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 54
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 53
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 50
The Vessels Contribute to Fibrosis in Systemic Sclerosis 50
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 50
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 49
The economic burden of fibromyalgia: A systematic literature review 48
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 47
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 47
Shulman, malattia di 47
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 46
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 46
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 46
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 45
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 45
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 45
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 44
Interferenza farmacologica "in vitro" sulla aderenza batterica agli spermatozoi 44
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 43
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 43
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 43
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects 43
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 42
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 42
Effects of cadmium (Cd) and zinc (Zn) ions on lymphocyte cultures. 42
il sistema immunitario 42
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 42
Development and implementation of the AIDA International Registry for patients with Behçet's disease 41
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 41
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 41
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 40
Emergenze cliniche in corso di allergia al veleno di imenotteri. 40
IL-6 production from peripheral blood mononuclear cells (PBMC) of patients affected by progressive systemic sclerosis (PSS). 40
Ultrastructural alterations of refrigerated vs cryopreserved human semen 40
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 40
Significato degli autoanticorpi antimiocardici nll'infarto miocardico. 39
Morphological study on the interaction between enterococci and human spermatozoa 39
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 39
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 39
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients 39
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 38
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders 38
Rituximab in primary Sjögren's syndrome: a ten-year journey 38
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 38
Totale 8.559
Categoria #
all - tutte 206.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/20265.778 1.556 496 1.216 2.243 267 0 0 0 0 0 0 0
Totale 19.397